Global Liposomes Drug Delivery Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Liposomes Drug Delivery market size is predicted to grow from US$ 3942 million in 2025 to US$ 7127 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Liposomes Drug Delivery Industry Forecast” looks at past sales and reviews total world Liposomes Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposomes Drug Delivery sales for 2025 through 2031. With Liposomes Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomes Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Liposomes Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomes Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposomes Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomes Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomes Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Liposomes Drug Delivery market?
What factors are driving Liposomes Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposomes Drug Delivery market opportunities vary by end market size?
How does Liposomes Drug Delivery break out by Type, by Application?
The global Liposomes Drug Delivery market size is predicted to grow from US$ 3942 million in 2025 to US$ 7127 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Liposomes Drug Delivery Industry Forecast” looks at past sales and reviews total world Liposomes Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Liposomes Drug Delivery sales for 2025 through 2031. With Liposomes Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposomes Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Liposomes Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposomes Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liposomes Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposomes Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposomes Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposomes Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Luye Pharma
- Sigma-Tau Group
- Fudan-Zhangjiang
- Teva Pharmaceutical
- CSPC
- Novartis
- Kingond Pharm
- Spectrum Pharmaceuticals
- Shanghai New Asia
What is the 10-year outlook for the global Liposomes Drug Delivery market?
What factors are driving Liposomes Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Liposomes Drug Delivery market opportunities vary by end market size?
How does Liposomes Drug Delivery break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liposomes Drug Delivery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liposomes Drug Delivery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liposomes Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Liposomes Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposomes Drug Delivery Sales by Type
2.3.1 Global Liposomes Drug Delivery Sales Market Share by Type (2020-2025)
2.3.2 Global Liposomes Drug Delivery Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liposomes Drug Delivery Sale Price by Type (2020-2025)
2.4 Liposomes Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposomes Drug Delivery Sales by Application
2.5.1 Global Liposomes Drug Delivery Sale Market Share by Application (2020-2025)
2.5.2 Global Liposomes Drug Delivery Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liposomes Drug Delivery Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Liposomes Drug Delivery Breakdown Data by Company
3.1.1 Global Liposomes Drug Delivery Annual Sales by Company (2020-2025)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Liposomes Drug Delivery Annual Revenue by Company (2020-2025)
3.2.1 Global Liposomes Drug Delivery Revenue by Company (2020-2025)
3.2.2 Global Liposomes Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Liposomes Drug Delivery Sale Price by Company
3.4 Key Manufacturers Liposomes Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposomes Drug Delivery Product Location Distribution
3.4.2 Players Liposomes Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIPOSOMES DRUG DELIVERY BY GEOGRAPHIC REGION
4.1 World Historic Liposomes Drug Delivery Market Size by Geographic Region (2020-2025)
4.1.1 Global Liposomes Drug Delivery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liposomes Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liposomes Drug Delivery Market Size by Country/Region (2020-2025)
4.2.1 Global Liposomes Drug Delivery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liposomes Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposomes Drug Delivery Sales Growth
4.4 APAC Liposomes Drug Delivery Sales Growth
4.5 Europe Liposomes Drug Delivery Sales Growth
4.6 Middle East & Africa Liposomes Drug Delivery Sales Growth
5 AMERICAS
5.1 Americas Liposomes Drug Delivery Sales by Country
5.1.1 Americas Liposomes Drug Delivery Sales by Country (2020-2025)
5.1.2 Americas Liposomes Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Liposomes Drug Delivery Sales by Type (2020-2025)
5.3 Americas Liposomes Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposomes Drug Delivery Sales by Region
6.1.1 APAC Liposomes Drug Delivery Sales by Region (2020-2025)
6.1.2 APAC Liposomes Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Liposomes Drug Delivery Sales by Type (2020-2025)
6.3 APAC Liposomes Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liposomes Drug Delivery by Country
7.1.1 Europe Liposomes Drug Delivery Sales by Country (2020-2025)
7.1.2 Europe Liposomes Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Liposomes Drug Delivery Sales by Type (2020-2025)
7.3 Europe Liposomes Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liposomes Drug Delivery by Country
8.1.1 Middle East & Africa Liposomes Drug Delivery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liposomes Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Liposomes Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Liposomes Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomes Drug Delivery
10.3 Manufacturing Process Analysis of Liposomes Drug Delivery
10.4 Industry Chain Structure of Liposomes Drug Delivery
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposomes Drug Delivery Distributors
11.3 Liposomes Drug Delivery Customer
12 WORLD FORECAST REVIEW FOR LIPOSOMES DRUG DELIVERY BY GEOGRAPHIC REGION
12.1 Global Liposomes Drug Delivery Market Size Forecast by Region
12.1.1 Global Liposomes Drug Delivery Forecast by Region (2026-2031)
12.1.2 Global Liposomes Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liposomes Drug Delivery Forecast by Type (2026-2031)
12.7 Global Liposomes Drug Delivery Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Liposomes Drug Delivery Product Portfolios and Specifications
13.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Liposomes Drug Delivery Product Portfolios and Specifications
13.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 Pacira
13.3.1 Pacira Company Information
13.3.2 Pacira Liposomes Drug Delivery Product Portfolios and Specifications
13.3.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pacira Main Business Overview
13.3.5 Pacira Latest Developments
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Information
13.4.2 Sun Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharmaceutical Main Business Overview
13.4.5 Sun Pharmaceutical Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposomes Drug Delivery Product Portfolios and Specifications
13.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Information
13.6.2 Sigma-Tau Group Liposomes Drug Delivery Product Portfolios and Specifications
13.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sigma-Tau Group Main Business Overview
13.6.5 Sigma-Tau Group Latest Developments
13.7 Fudan-Zhangjiang
13.7.1 Fudan-Zhangjiang Company Information
13.7.2 Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolios and Specifications
13.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fudan-Zhangjiang Main Business Overview
13.7.5 Fudan-Zhangjiang Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 CSPC
13.9.1 CSPC Company Information
13.9.2 CSPC Liposomes Drug Delivery Product Portfolios and Specifications
13.9.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CSPC Main Business Overview
13.9.5 CSPC Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposomes Drug Delivery Product Portfolios and Specifications
13.10.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Kingond Pharm
13.11.1 Kingond Pharm Company Information
13.11.2 Kingond Pharm Liposomes Drug Delivery Product Portfolios and Specifications
13.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Kingond Pharm Main Business Overview
13.11.5 Kingond Pharm Latest Developments
13.12 Spectrum Pharmaceuticals
13.12.1 Spectrum Pharmaceuticals Company Information
13.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolios and Specifications
13.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Spectrum Pharmaceuticals Main Business Overview
13.12.5 Spectrum Pharmaceuticals Latest Developments
13.13 Shanghai New Asia
13.13.1 Shanghai New Asia Company Information
13.13.2 Shanghai New Asia Liposomes Drug Delivery Product Portfolios and Specifications
13.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shanghai New Asia Main Business Overview
13.13.5 Shanghai New Asia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Liposomes Drug Delivery Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liposomes Drug Delivery Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 8. Global Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Table 9. Global Liposomes Drug Delivery Revenue byType (2020-2025) & ($ million)
Table 10. Global Liposomes Drug Delivery Revenue Market Share byType (2020-2025)
Table 11. Global Liposomes Drug Delivery Sale Price byType (2020-2025) & (USD/Vial)
Table 12. Global Liposomes Drug Delivery Sale by Application (2020-2025) & (K Vials)
Table 13. Global Liposomes Drug Delivery Sale Market Share by Application (2020-2025)
Table 14. Global Liposomes Drug Delivery Revenue by Application (2020-2025) & ($ million)
Table 15. Global Liposomes Drug Delivery Revenue Market Share by Application (2020-2025)
Table 16. Global Liposomes Drug Delivery Sale Price by Application (2020-2025) & (USD/Vial)
Table 17. Global Liposomes Drug Delivery Sales by Company (2020-2025) & (K Vials)
Table 18. Global Liposomes Drug Delivery Sales Market Share by Company (2020-2025)
Table 19. Global Liposomes Drug Delivery Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Liposomes Drug Delivery Revenue Market Share by Company (2020-2025)
Table 21. Global Liposomes Drug Delivery Sale Price by Company (2020-2025) & (USD/Vial)
Table 22. Key Manufacturers Liposomes Drug Delivery Producing Area Distribution and Sales Area
Table 23. Players Liposomes Drug Delivery Products Offered
Table 24. Liposomes Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Liposomes Drug Delivery Sales by Geographic Region (2020-2025) & (K Vials)
Table 28. Global Liposomes Drug Delivery Sales Market Share Geographic Region (2020-2025)
Table 29. Global Liposomes Drug Delivery Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Liposomes Drug Delivery Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Liposomes Drug Delivery Sales by Country/Region (2020-2025) & (K Vials)
Table 32. Global Liposomes Drug Delivery Sales Market Share by Country/Region (2020-2025)
Table 33. Global Liposomes Drug Delivery Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Liposomes Drug Delivery Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 36. Americas Liposomes Drug Delivery Sales Market Share by Country (2020-2025)
Table 37. Americas Liposomes Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 39. Americas Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 40. APAC Liposomes Drug Delivery Sales by Region (2020-2025) & (K Vials)
Table 41. APAC Liposomes Drug Delivery Sales Market Share by Region (2020-2025)
Table 42. APAC Liposomes Drug Delivery Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 44. APAC Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 45. Europe Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 46. Europe Liposomes Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 48. Europe Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 49. Middle East & Africa Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 50. Middle East & Africa Liposomes Drug Delivery Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 52. Middle East & Africa Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 53. Key Market Drivers & Growth Opportunities of Liposomes Drug Delivery
Table 54. Key Market Challenges & Risks of Liposomes Drug Delivery
Table 55. Key IndustryTrends of Liposomes Drug Delivery
Table 56. Liposomes Drug Delivery Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Liposomes Drug Delivery Distributors List
Table 59. Liposomes Drug Delivery Customer List
Table 60. Global Liposomes Drug Delivery SalesForecast by Region (2026-2031) & (K Vials)
Table 61. Global Liposomes Drug Delivery RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Liposomes Drug Delivery SalesForecast by Country (2026-2031) & (K Vials)
Table 63. Americas Liposomes Drug Delivery Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Liposomes Drug Delivery SalesForecast by Region (2026-2031) & (K Vials)
Table 65. APAC Liposomes Drug Delivery Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Liposomes Drug Delivery SalesForecast by Country (2026-2031) & (K Vials)
Table 67. Europe Liposomes Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Liposomes Drug Delivery SalesForecast by Country (2026-2031) & (K Vials)
Table 69. Middle East & Africa Liposomes Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Liposomes Drug Delivery SalesForecast byType (2026-2031) & (K Vials)
Table 71. Global Liposomes Drug Delivery RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Liposomes Drug Delivery SalesForecast by Application (2026-2031) & (K Vials)
Table 73. Global Liposomes Drug Delivery RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Johnson & Johnson Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 75. Johnson & Johnson Liposomes Drug Delivery Product Portfolios and Specifications
Table 76. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. Gilead Sciences Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 80. Gilead Sciences Liposomes Drug Delivery Product Portfolios and Specifications
Table 81. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 82. Gilead Sciences Main Business
Table 83. Gilead Sciences Latest Developments
Table 84. Pacira Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 85. Pacira Liposomes Drug Delivery Product Portfolios and Specifications
Table 86. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 87. Pacira Main Business
Table 88. Pacira Latest Developments
Table 89. Sun Pharmaceutical Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 90. Sun Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
Table 91. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 92. Sun Pharmaceutical Main Business
Table 93. Sun Pharmaceutical Latest Developments
Table 94. Luye Pharma Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 95. Luye Pharma Liposomes Drug Delivery Product Portfolios and Specifications
Table 96. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 97. Luye Pharma Main Business
Table 98. Luye Pharma Latest Developments
Table 99. Sigma-Tau Group Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 100. Sigma-Tau Group Liposomes Drug Delivery Product Portfolios and Specifications
Table 101. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 102. Sigma-Tau Group Main Business
Table 103. Sigma-Tau Group Latest Developments
Table 104.Fudan-Zhangjiang Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 105.Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolios and Specifications
Table 106.Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 107.Fudan-Zhangjiang Main Business
Table 108.Fudan-Zhangjiang Latest Developments
Table 109.Teva Pharmaceutical Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 110.Teva Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
Table 111.Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112.Teva Pharmaceutical Main Business
Table 113.Teva Pharmaceutical Latest Developments
Table 114. CSPC Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Liposomes Drug Delivery Product Portfolios and Specifications
Table 116. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 117. CSPC Main Business
Table 118. CSPC Latest Developments
Table 119. Novartis Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Liposomes Drug Delivery Product Portfolios and Specifications
Table 121. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. Kingond Pharm Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 125. Kingond Pharm Liposomes Drug Delivery Product Portfolios and Specifications
Table 126. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 127. Kingond Pharm Main Business
Table 128. Kingond Pharm Latest Developments
Table 129. Spectrum Pharmaceuticals Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 130. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolios and Specifications
Table 131. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 132. Spectrum Pharmaceuticals Main Business
Table 133. Spectrum Pharmaceuticals Latest Developments
Table 134. Shanghai New Asia Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai New Asia Liposomes Drug Delivery Product Portfolios and Specifications
Table 136. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 137. Shanghai New Asia Main Business
Table 138. Shanghai New Asia Latest Developments
LIST OFFIGURES
Figure 1. Picture of Liposomes Drug Delivery
Figure 2. Liposomes Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomes Drug Delivery Sales Growth Rate 2020-2031 (K Vials)
Figure 7. Global Liposomes Drug Delivery Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liposomes Drug Delivery Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liposomes Drug Delivery Sales Market Share by Country/Region (2024)
Figure 10. Liposomes Drug Delivery Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liposomal Doxorubicin
Figure 12. Product Picture of Liposomal Amphoteracin B
Figure 13. Product Picture of Liposomal Paclitaxel
Figure 14. Product Picture of Others
Figure 15. Global Liposomes Drug Delivery Sales Market Share byType in 2025
Figure 16. Global Liposomes Drug Delivery Revenue Market Share byType (2020-2025)
Figure 17. Liposomes Drug Delivery Consumed inFungal InfectionTherapy
Figure 18. Global Liposomes Drug Delivery Market:Fungal InfectionTherapy (2020-2025) & (K Vials)
Figure 19. Liposomes Drug Delivery Consumed in Cancer &TumorTherapy
Figure 20. Global Liposomes Drug Delivery Market: Cancer &TumorTherapy (2020-2025) & (K Vials)
Figure 21. Liposomes Drug Delivery Consumed in Others
Figure 22. Global Liposomes Drug Delivery Market: Others (2020-2025) & (K Vials)
Figure 23. Global Liposomes Drug Delivery Sale Market Share by Application (2024)
Figure 24. Global Liposomes Drug Delivery Revenue Market Share by Application in 2025
Figure 25. Liposomes Drug Delivery Sales by Company in 2025 (K Vials)
Figure 26. Global Liposomes Drug Delivery Sales Market Share by Company in 2025
Figure 27. Liposomes Drug Delivery Revenue by Company in 2025 ($ millions)
Figure 28. Global Liposomes Drug Delivery Revenue Market Share by Company in 2025
Figure 29. Global Liposomes Drug Delivery Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Liposomes Drug Delivery Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 32. Americas Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 33. APAC Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 34. APAC Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 35. Europe Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 36. Europe Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 38. Middle East & Africa Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 39. Americas Liposomes Drug Delivery Sales Market Share by Country in 2025
Figure 40. Americas Liposomes Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 41. Americas Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 42. Americas Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 43. United States Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Liposomes Drug Delivery Sales Market Share by Region in 2025
Figure 48. APAC Liposomes Drug Delivery Revenue Market Share by Region (2020-2025)
Figure 49. APAC Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 50. APAC Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 51. China Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 55. India Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Liposomes Drug Delivery Sales Market Share by Country in 2025
Figure 59. Europe Liposomes Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 60. Europe Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 61. Europe Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 62. Germany Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 63.France Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Liposomes Drug Delivery Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 70. Egypt Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Liposomes Drug Delivery in 2025
Figure 76. Manufacturing Process Analysis of Liposomes Drug Delivery
Figure 77. Industry Chain Structure of Liposomes Drug Delivery
Figure 78. Channels of Distribution
Figure 79. Global Liposomes Drug Delivery Sales MarketForecast by Region (2026-2031)
Figure 80. Global Liposomes Drug Delivery Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Liposomes Drug Delivery Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Liposomes Drug Delivery Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Liposomes Drug Delivery Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Liposomes Drug Delivery Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Liposomes Drug Delivery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Liposomes Drug Delivery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Liposomes Drug Delivery by Country/Region, 2020, 2024 & 2031
2.2 Liposomes Drug Delivery Segment by Type
2.2.1 Liposomal Doxorubicin
2.2.2 Liposomal Amphoteracin B
2.2.3 Liposomal Paclitaxel
2.2.4 Others
2.3 Liposomes Drug Delivery Sales by Type
2.3.1 Global Liposomes Drug Delivery Sales Market Share by Type (2020-2025)
2.3.2 Global Liposomes Drug Delivery Revenue and Market Share by Type (2020-2025)
2.3.3 Global Liposomes Drug Delivery Sale Price by Type (2020-2025)
2.4 Liposomes Drug Delivery Segment by Application
2.4.1 Fungal Infection Therapy
2.4.2 Cancer & Tumor Therapy
2.4.3 Others
2.5 Liposomes Drug Delivery Sales by Application
2.5.1 Global Liposomes Drug Delivery Sale Market Share by Application (2020-2025)
2.5.2 Global Liposomes Drug Delivery Revenue and Market Share by Application (2020-2025)
2.5.3 Global Liposomes Drug Delivery Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Liposomes Drug Delivery Breakdown Data by Company
3.1.1 Global Liposomes Drug Delivery Annual Sales by Company (2020-2025)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Company (2020-2025)
3.2 Global Liposomes Drug Delivery Annual Revenue by Company (2020-2025)
3.2.1 Global Liposomes Drug Delivery Revenue by Company (2020-2025)
3.2.2 Global Liposomes Drug Delivery Revenue Market Share by Company (2020-2025)
3.3 Global Liposomes Drug Delivery Sale Price by Company
3.4 Key Manufacturers Liposomes Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liposomes Drug Delivery Product Location Distribution
3.4.2 Players Liposomes Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIPOSOMES DRUG DELIVERY BY GEOGRAPHIC REGION
4.1 World Historic Liposomes Drug Delivery Market Size by Geographic Region (2020-2025)
4.1.1 Global Liposomes Drug Delivery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Liposomes Drug Delivery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Liposomes Drug Delivery Market Size by Country/Region (2020-2025)
4.2.1 Global Liposomes Drug Delivery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Liposomes Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liposomes Drug Delivery Sales Growth
4.4 APAC Liposomes Drug Delivery Sales Growth
4.5 Europe Liposomes Drug Delivery Sales Growth
4.6 Middle East & Africa Liposomes Drug Delivery Sales Growth
5 AMERICAS
5.1 Americas Liposomes Drug Delivery Sales by Country
5.1.1 Americas Liposomes Drug Delivery Sales by Country (2020-2025)
5.1.2 Americas Liposomes Drug Delivery Revenue by Country (2020-2025)
5.2 Americas Liposomes Drug Delivery Sales by Type (2020-2025)
5.3 Americas Liposomes Drug Delivery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposomes Drug Delivery Sales by Region
6.1.1 APAC Liposomes Drug Delivery Sales by Region (2020-2025)
6.1.2 APAC Liposomes Drug Delivery Revenue by Region (2020-2025)
6.2 APAC Liposomes Drug Delivery Sales by Type (2020-2025)
6.3 APAC Liposomes Drug Delivery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Liposomes Drug Delivery by Country
7.1.1 Europe Liposomes Drug Delivery Sales by Country (2020-2025)
7.1.2 Europe Liposomes Drug Delivery Revenue by Country (2020-2025)
7.2 Europe Liposomes Drug Delivery Sales by Type (2020-2025)
7.3 Europe Liposomes Drug Delivery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Liposomes Drug Delivery by Country
8.1.1 Middle East & Africa Liposomes Drug Delivery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Liposomes Drug Delivery Revenue by Country (2020-2025)
8.2 Middle East & Africa Liposomes Drug Delivery Sales by Type (2020-2025)
8.3 Middle East & Africa Liposomes Drug Delivery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liposomes Drug Delivery
10.3 Manufacturing Process Analysis of Liposomes Drug Delivery
10.4 Industry Chain Structure of Liposomes Drug Delivery
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liposomes Drug Delivery Distributors
11.3 Liposomes Drug Delivery Customer
12 WORLD FORECAST REVIEW FOR LIPOSOMES DRUG DELIVERY BY GEOGRAPHIC REGION
12.1 Global Liposomes Drug Delivery Market Size Forecast by Region
12.1.1 Global Liposomes Drug Delivery Forecast by Region (2026-2031)
12.1.2 Global Liposomes Drug Delivery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Liposomes Drug Delivery Forecast by Type (2026-2031)
12.7 Global Liposomes Drug Delivery Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Liposomes Drug Delivery Product Portfolios and Specifications
13.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Information
13.2.2 Gilead Sciences Liposomes Drug Delivery Product Portfolios and Specifications
13.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Gilead Sciences Main Business Overview
13.2.5 Gilead Sciences Latest Developments
13.3 Pacira
13.3.1 Pacira Company Information
13.3.2 Pacira Liposomes Drug Delivery Product Portfolios and Specifications
13.3.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Pacira Main Business Overview
13.3.5 Pacira Latest Developments
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Information
13.4.2 Sun Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
13.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharmaceutical Main Business Overview
13.4.5 Sun Pharmaceutical Latest Developments
13.5 Luye Pharma
13.5.1 Luye Pharma Company Information
13.5.2 Luye Pharma Liposomes Drug Delivery Product Portfolios and Specifications
13.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Luye Pharma Main Business Overview
13.5.5 Luye Pharma Latest Developments
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Information
13.6.2 Sigma-Tau Group Liposomes Drug Delivery Product Portfolios and Specifications
13.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sigma-Tau Group Main Business Overview
13.6.5 Sigma-Tau Group Latest Developments
13.7 Fudan-Zhangjiang
13.7.1 Fudan-Zhangjiang Company Information
13.7.2 Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolios and Specifications
13.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fudan-Zhangjiang Main Business Overview
13.7.5 Fudan-Zhangjiang Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 CSPC
13.9.1 CSPC Company Information
13.9.2 CSPC Liposomes Drug Delivery Product Portfolios and Specifications
13.9.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CSPC Main Business Overview
13.9.5 CSPC Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Liposomes Drug Delivery Product Portfolios and Specifications
13.10.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Kingond Pharm
13.11.1 Kingond Pharm Company Information
13.11.2 Kingond Pharm Liposomes Drug Delivery Product Portfolios and Specifications
13.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Kingond Pharm Main Business Overview
13.11.5 Kingond Pharm Latest Developments
13.12 Spectrum Pharmaceuticals
13.12.1 Spectrum Pharmaceuticals Company Information
13.12.2 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolios and Specifications
13.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Spectrum Pharmaceuticals Main Business Overview
13.12.5 Spectrum Pharmaceuticals Latest Developments
13.13 Shanghai New Asia
13.13.1 Shanghai New Asia Company Information
13.13.2 Shanghai New Asia Liposomes Drug Delivery Product Portfolios and Specifications
13.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shanghai New Asia Main Business Overview
13.13.5 Shanghai New Asia Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Liposomes Drug Delivery Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Liposomes Drug Delivery Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liposomal Doxorubicin
Table 4. Major Players of Liposomal Amphoteracin B
Table 5. Major Players of Liposomal Paclitaxel
Table 6. Major Players of Others
Table 7. Global Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 8. Global Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Table 9. Global Liposomes Drug Delivery Revenue byType (2020-2025) & ($ million)
Table 10. Global Liposomes Drug Delivery Revenue Market Share byType (2020-2025)
Table 11. Global Liposomes Drug Delivery Sale Price byType (2020-2025) & (USD/Vial)
Table 12. Global Liposomes Drug Delivery Sale by Application (2020-2025) & (K Vials)
Table 13. Global Liposomes Drug Delivery Sale Market Share by Application (2020-2025)
Table 14. Global Liposomes Drug Delivery Revenue by Application (2020-2025) & ($ million)
Table 15. Global Liposomes Drug Delivery Revenue Market Share by Application (2020-2025)
Table 16. Global Liposomes Drug Delivery Sale Price by Application (2020-2025) & (USD/Vial)
Table 17. Global Liposomes Drug Delivery Sales by Company (2020-2025) & (K Vials)
Table 18. Global Liposomes Drug Delivery Sales Market Share by Company (2020-2025)
Table 19. Global Liposomes Drug Delivery Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Liposomes Drug Delivery Revenue Market Share by Company (2020-2025)
Table 21. Global Liposomes Drug Delivery Sale Price by Company (2020-2025) & (USD/Vial)
Table 22. Key Manufacturers Liposomes Drug Delivery Producing Area Distribution and Sales Area
Table 23. Players Liposomes Drug Delivery Products Offered
Table 24. Liposomes Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Liposomes Drug Delivery Sales by Geographic Region (2020-2025) & (K Vials)
Table 28. Global Liposomes Drug Delivery Sales Market Share Geographic Region (2020-2025)
Table 29. Global Liposomes Drug Delivery Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Liposomes Drug Delivery Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Liposomes Drug Delivery Sales by Country/Region (2020-2025) & (K Vials)
Table 32. Global Liposomes Drug Delivery Sales Market Share by Country/Region (2020-2025)
Table 33. Global Liposomes Drug Delivery Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Liposomes Drug Delivery Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 36. Americas Liposomes Drug Delivery Sales Market Share by Country (2020-2025)
Table 37. Americas Liposomes Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 39. Americas Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 40. APAC Liposomes Drug Delivery Sales by Region (2020-2025) & (K Vials)
Table 41. APAC Liposomes Drug Delivery Sales Market Share by Region (2020-2025)
Table 42. APAC Liposomes Drug Delivery Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 44. APAC Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 45. Europe Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 46. Europe Liposomes Drug Delivery Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 48. Europe Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 49. Middle East & Africa Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 50. Middle East & Africa Liposomes Drug Delivery Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Liposomes Drug Delivery Sales byType (2020-2025) & (K Vials)
Table 52. Middle East & Africa Liposomes Drug Delivery Sales by Application (2020-2025) & (K Vials)
Table 53. Key Market Drivers & Growth Opportunities of Liposomes Drug Delivery
Table 54. Key Market Challenges & Risks of Liposomes Drug Delivery
Table 55. Key IndustryTrends of Liposomes Drug Delivery
Table 56. Liposomes Drug Delivery Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Liposomes Drug Delivery Distributors List
Table 59. Liposomes Drug Delivery Customer List
Table 60. Global Liposomes Drug Delivery SalesForecast by Region (2026-2031) & (K Vials)
Table 61. Global Liposomes Drug Delivery RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Liposomes Drug Delivery SalesForecast by Country (2026-2031) & (K Vials)
Table 63. Americas Liposomes Drug Delivery Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Liposomes Drug Delivery SalesForecast by Region (2026-2031) & (K Vials)
Table 65. APAC Liposomes Drug Delivery Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Liposomes Drug Delivery SalesForecast by Country (2026-2031) & (K Vials)
Table 67. Europe Liposomes Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Liposomes Drug Delivery SalesForecast by Country (2026-2031) & (K Vials)
Table 69. Middle East & Africa Liposomes Drug Delivery RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Liposomes Drug Delivery SalesForecast byType (2026-2031) & (K Vials)
Table 71. Global Liposomes Drug Delivery RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Liposomes Drug Delivery SalesForecast by Application (2026-2031) & (K Vials)
Table 73. Global Liposomes Drug Delivery RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Johnson & Johnson Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 75. Johnson & Johnson Liposomes Drug Delivery Product Portfolios and Specifications
Table 76. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Latest Developments
Table 79. Gilead Sciences Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 80. Gilead Sciences Liposomes Drug Delivery Product Portfolios and Specifications
Table 81. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 82. Gilead Sciences Main Business
Table 83. Gilead Sciences Latest Developments
Table 84. Pacira Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 85. Pacira Liposomes Drug Delivery Product Portfolios and Specifications
Table 86. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 87. Pacira Main Business
Table 88. Pacira Latest Developments
Table 89. Sun Pharmaceutical Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 90. Sun Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
Table 91. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 92. Sun Pharmaceutical Main Business
Table 93. Sun Pharmaceutical Latest Developments
Table 94. Luye Pharma Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 95. Luye Pharma Liposomes Drug Delivery Product Portfolios and Specifications
Table 96. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 97. Luye Pharma Main Business
Table 98. Luye Pharma Latest Developments
Table 99. Sigma-Tau Group Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 100. Sigma-Tau Group Liposomes Drug Delivery Product Portfolios and Specifications
Table 101. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 102. Sigma-Tau Group Main Business
Table 103. Sigma-Tau Group Latest Developments
Table 104.Fudan-Zhangjiang Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 105.Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolios and Specifications
Table 106.Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 107.Fudan-Zhangjiang Main Business
Table 108.Fudan-Zhangjiang Latest Developments
Table 109.Teva Pharmaceutical Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 110.Teva Pharmaceutical Liposomes Drug Delivery Product Portfolios and Specifications
Table 111.Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 112.Teva Pharmaceutical Main Business
Table 113.Teva Pharmaceutical Latest Developments
Table 114. CSPC Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 115. CSPC Liposomes Drug Delivery Product Portfolios and Specifications
Table 116. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 117. CSPC Main Business
Table 118. CSPC Latest Developments
Table 119. Novartis Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Liposomes Drug Delivery Product Portfolios and Specifications
Table 121. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. Kingond Pharm Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 125. Kingond Pharm Liposomes Drug Delivery Product Portfolios and Specifications
Table 126. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 127. Kingond Pharm Main Business
Table 128. Kingond Pharm Latest Developments
Table 129. Spectrum Pharmaceuticals Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 130. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolios and Specifications
Table 131. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 132. Spectrum Pharmaceuticals Main Business
Table 133. Spectrum Pharmaceuticals Latest Developments
Table 134. Shanghai New Asia Basic Information, Liposomes Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai New Asia Liposomes Drug Delivery Product Portfolios and Specifications
Table 136. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 137. Shanghai New Asia Main Business
Table 138. Shanghai New Asia Latest Developments
LIST OFFIGURES
Figure 1. Picture of Liposomes Drug Delivery
Figure 2. Liposomes Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liposomes Drug Delivery Sales Growth Rate 2020-2031 (K Vials)
Figure 7. Global Liposomes Drug Delivery Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Liposomes Drug Delivery Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Liposomes Drug Delivery Sales Market Share by Country/Region (2024)
Figure 10. Liposomes Drug Delivery Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liposomal Doxorubicin
Figure 12. Product Picture of Liposomal Amphoteracin B
Figure 13. Product Picture of Liposomal Paclitaxel
Figure 14. Product Picture of Others
Figure 15. Global Liposomes Drug Delivery Sales Market Share byType in 2025
Figure 16. Global Liposomes Drug Delivery Revenue Market Share byType (2020-2025)
Figure 17. Liposomes Drug Delivery Consumed inFungal InfectionTherapy
Figure 18. Global Liposomes Drug Delivery Market:Fungal InfectionTherapy (2020-2025) & (K Vials)
Figure 19. Liposomes Drug Delivery Consumed in Cancer &TumorTherapy
Figure 20. Global Liposomes Drug Delivery Market: Cancer &TumorTherapy (2020-2025) & (K Vials)
Figure 21. Liposomes Drug Delivery Consumed in Others
Figure 22. Global Liposomes Drug Delivery Market: Others (2020-2025) & (K Vials)
Figure 23. Global Liposomes Drug Delivery Sale Market Share by Application (2024)
Figure 24. Global Liposomes Drug Delivery Revenue Market Share by Application in 2025
Figure 25. Liposomes Drug Delivery Sales by Company in 2025 (K Vials)
Figure 26. Global Liposomes Drug Delivery Sales Market Share by Company in 2025
Figure 27. Liposomes Drug Delivery Revenue by Company in 2025 ($ millions)
Figure 28. Global Liposomes Drug Delivery Revenue Market Share by Company in 2025
Figure 29. Global Liposomes Drug Delivery Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Liposomes Drug Delivery Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 32. Americas Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 33. APAC Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 34. APAC Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 35. Europe Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 36. Europe Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Liposomes Drug Delivery Sales 2020-2025 (K Vials)
Figure 38. Middle East & Africa Liposomes Drug Delivery Revenue 2020-2025 ($ millions)
Figure 39. Americas Liposomes Drug Delivery Sales Market Share by Country in 2025
Figure 40. Americas Liposomes Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 41. Americas Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 42. Americas Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 43. United States Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Liposomes Drug Delivery Sales Market Share by Region in 2025
Figure 48. APAC Liposomes Drug Delivery Revenue Market Share by Region (2020-2025)
Figure 49. APAC Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 50. APAC Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 51. China Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 55. India Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Liposomes Drug Delivery Sales Market Share by Country in 2025
Figure 59. Europe Liposomes Drug Delivery Revenue Market Share by Country (2020-2025)
Figure 60. Europe Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 61. Europe Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 62. Germany Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 63.France Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Liposomes Drug Delivery Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Liposomes Drug Delivery Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Figure 70. Egypt Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Liposomes Drug Delivery Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Liposomes Drug Delivery in 2025
Figure 76. Manufacturing Process Analysis of Liposomes Drug Delivery
Figure 77. Industry Chain Structure of Liposomes Drug Delivery
Figure 78. Channels of Distribution
Figure 79. Global Liposomes Drug Delivery Sales MarketForecast by Region (2026-2031)
Figure 80. Global Liposomes Drug Delivery Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Liposomes Drug Delivery Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Liposomes Drug Delivery Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Liposomes Drug Delivery Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Liposomes Drug Delivery Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Glucagon Market Growth 2025-2031
US$ 3,660.00
March 2025
88 pages
Global Belimumab Market Growth 2025-2031
US$ 3,660.00
December 2025
76 pages
